Vascular

Nasser Mikhail, MD, MSc
Chief, Endocrinology Division, Olive View-University of California at Los Angeles Medical Center, Sylmar, CA

Nasser Mikhail, MD, MSc
Chief, Endocrinology Division, Olive View-University of California at Los Angeles Medical Center, Sylmar, CA

Nasser Mikhail, MD, MSc
Chief, Endocrinology Division, Olive View-University of California at Los Angeles Medical Center, Sylmar, CA

Derk W. Krieger, MD
Section of Stroke and Neurological Intensive Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, Section of Stroke and Neurological Intensive Care, The Cleveland Clinic Foundation, S91, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Derk W. Krieger, MD
Section of Stroke and Neurological Intensive Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, Section of Stroke and Neurological Intensive Care, The Cleveland Clinic Foundation, S91, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Derk W. Krieger, MD
Section of Stroke and Neurological Intensive Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, Section of Stroke and Neurological Intensive Care, The Cleveland Clinic Foundation, S91, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: Carol Langford, MD, MHS, Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

No therapeutic agents are specifically approved for the treatment of Wegener granulomatosis. All references to a commercial product constitute an unlabeled use.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: Carol Langford, MD, MHS, Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

No therapeutic agents are specifically approved for the treatment of Wegener granulomatosis. All references to a commercial product constitute an unlabeled use.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: Carol Langford, MD, MHS, Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

No therapeutic agents are specifically approved for the treatment of Wegener granulomatosis. All references to a commercial product constitute an unlabeled use.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Richard L. Dunbar, MD
Attending Physician, Cardiovascular Risk Intervention Program; Instructor of Medicine; University of Pennsylvania School of Medicine, Philadelphia

Daniel J. Rader, MD
Associate Professor of Medicine, Pharmacology, and Pathology; Director, General Clinical Research Center; Associate Director, Institute for Translational Medicine and Therapeutics; University of Pennsylvania School of Medicine, Philadelphia

Address: Richard L. Dunbar, MD, PHI building, Suite 351, 39th and Market Streets; Philadelphia, PA 19104, e-mail [email protected]

The authors’ work is supported by grants from the National Institutes of Health (T32-HL-07443-25 and KIZ-RR017625-03).

Richard L. Dunbar, MD
Attending Physician, Cardiovascular Risk Intervention Program; Instructor of Medicine; University of Pennsylvania School of Medicine, Philadelphia

Daniel J. Rader, MD
Associate Professor of Medicine, Pharmacology, and Pathology; Director, General Clinical Research Center; Associate Director, Institute for Translational Medicine and Therapeutics; University of Pennsylvania School of Medicine, Philadelphia

Address: Richard L. Dunbar, MD, PHI building, Suite 351, 39th and Market Streets; Philadelphia, PA 19104, e-mail [email protected]

The authors’ work is supported by grants from the National Institutes of Health (T32-HL-07443-25 and KIZ-RR017625-03).

Richard L. Dunbar, MD
Attending Physician, Cardiovascular Risk Intervention Program; Instructor of Medicine; University of Pennsylvania School of Medicine, Philadelphia

Daniel J. Rader, MD
Associate Professor of Medicine, Pharmacology, and Pathology; Director, General Clinical Research Center; Associate Director, Institute for Translational Medicine and Therapeutics; University of Pennsylvania School of Medicine, Philadelphia

Address: Richard L. Dunbar, MD, PHI building, Suite 351, 39th and Market Streets; Philadelphia, PA 19104, e-mail [email protected]

The authors’ work is supported by grants from the National Institutes of Health (T32-HL-07443-25 and KIZ-RR017625-03).

Bryson Borg, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Brian R. Herts, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Thomas J. Masaryk, MD
Head, Section of Neuroradiology, Department of Diagnostic Radiology, and the Department of Neurologic Surgery, The Cleveland Clinic Foundation

Address: Bryson Borg, MD, Department of Diagnostic Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Bryson Borg, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Brian R. Herts, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Thomas J. Masaryk, MD
Head, Section of Neuroradiology, Department of Diagnostic Radiology, and the Department of Neurologic Surgery, The Cleveland Clinic Foundation

Address: Bryson Borg, MD, Department of Diagnostic Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Bryson Borg, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Brian R. Herts, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Thomas J. Masaryk, MD
Head, Section of Neuroradiology, Department of Diagnostic Radiology, and the Department of Neurologic Surgery, The Cleveland Clinic Foundation

Address: Bryson Borg, MD, Department of Diagnostic Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Brian F. Mandell, MD, PhD
Editor in Chief

Brian F. Mandell, MD, PhD
Editor in Chief

Brian F. Mandell, MD, PhD
Editor in Chief

Paul Schoenhagen, MD
Department of Radiology, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Steven E. Nissen, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Paul Schoenhagen, MD, Department of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The authors have indicated that they have received research support from the Pfizer, Merck, AstraZeneca, Sankyo, and Takeda corporations.

Paul Schoenhagen, MD
Department of Radiology, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Steven E. Nissen, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Paul Schoenhagen, MD, Department of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The authors have indicated that they have received research support from the Pfizer, Merck, AstraZeneca, Sankyo, and Takeda corporations.

Paul Schoenhagen, MD
Department of Radiology, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Steven E. Nissen, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Paul Schoenhagen, MD, Department of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The authors have indicated that they have received research support from the Pfizer, Merck, AstraZeneca, Sankyo, and Takeda corporations.